VULCAN FORGING CUPID'S WINGJACOBSON M. A.ART (THE) BULLETIN. 1972, Vol 54, Num 4, pp 418-429Article

Valaciclovir (BW256U87) : the L-valyl ester of acyclovirJACOBSON, M. A.Journal of medical virology. 1993, pp 150-153, issn 0146-6615, SUP1Conference Paper

Current management of cytomegalovirus disease in patients with AIDS : Tenth anniversary perspectives on AIDS : clinical investigation of HIV diseaseJACOBSON, M. A.AIDS research and human retroviruses. 1994, Vol 10, Num 8, pp 917-923, issn 0889-2229Conference Paper

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeJACOBSON, M. A.The New England journal of medicine. 1997, Vol 337, Num 2, pp 105-114, issn 0028-4793Article

Passenger cass: energy accounting «The effect of traffic flow, average speed and driving style on fuel consumption of European motor cars»JACOBSON, M. A.International FISITA congress. 19. sd, pp 79.1-79.4Conference Paper

Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendationsAWEEKA, F. T; JACOBSON, M. A; MARTIN-MUNLEY, S et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1999, Vol 20, Num 4, pp 350-357, issn 1077-9450Conference Paper

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapyJACOBSON, M. A; ZEGANS, M; PAVAN, P. R et al.Lancet (British edition). 1997, Vol 349, Num 9063, pp 1443-1445, issn 0140-6736Article

Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus diseaseJACOBSON, M. A; GALLANT, J; WANG, L. H et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 7, pp 1534-1540, issn 0066-4804Article

Ecological risk assessment for river sediments contaminated by creosotePASTOROK, R. A; PEEK, D. C; SAMPSON, J. R et al.Environmental toxicology and chemistry. 1994, Vol 13, Num 12, pp 1929-1941, issn 0730-7268Conference Paper

Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitisJACOBSON, M. A; BESCH, C. L; CHILD, C et al.Lancet (British edition). 1992, Vol 339, Num 8789, pp 333-334, issn 0140-6736Article

Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolismJACOBSON, M. A; GAMBERTOGLIO, J. G; AWEEKA, F. T et al.The Journal of clinical endocrinology and metabolism. 1991, Vol 72, Num 5, pp 1130-1135, issn 0021-972X, 6 p.Article

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitisAWEEKA, F; GAMBERTOGLIO, J; MILLS, J et al.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 5, pp 742-745, issn 0066-4804Article

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitisJACOBSON, M. A; O'DONNELL, J. J; BRODIE, H. R et al.Journal of medical virology. 1988, Vol 25, Num 3, pp 339-349, issn 0146-6615Article

Human pharmacokinetics and tolerance of oral ganciclovirJACOBSON, M. A; DE MIRANDA, P; CEDERBERG, D. M et al.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 8, pp 1251-1254, issn 0066-4804Article

Control of carrier concentration by stimulated emission in highly excited direct gap semiconductorsEGOROV, V. D; MÜLLER, G. O; WEBER, H. H et al.Physica status solidi. B. Basic research. 1984, Vol 122, Num 1, pp 183-192, issn 0370-1972Article

Resonance energy transfer between the adenosine 5'-diphosphate site of glutamate dehydrogenase and a guanosine 5'-triphosphate site containing a tyrosine labeled with 5'-[p-(fluorosulfonyl)benzoyl]-1,N⁶-ethenoadenosineJACOBSON, M. A; COLMAN, R. F.Biochemistry (Easton). 1983, Vol 22, Num 18, pp 4247-4257, issn 0006-2960Article

Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome : foscarnetJACOBSON, M. A.The American journal of medicine. 1992, Vol 92, Num 2A, pp 2A.26S-2A.29S, issn 0002-9343Conference Paper

AIDS : clinical review 1989VOLBERDING, P; JACOBSON, M. A.Journal of medicine (Westbury). 1990, Vol 21, Num 3-4, pp 220-222, issn 0025-7850Article

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatmentJACOBSON, M. A; MILLS, J.Annals of internal medicine. 1988, Vol 108, Num 4, pp 585-594, issn 0003-4819Article

Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapyJACOBSON, M. A; FRENCH, M.AIDS (Supplement). 1998, Vol 12, Num A, pp 157-163, issn 1350-2840Article

Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapyJACOBSON, M. A; STANLEY, H; HOLTZER, C et al.Clinical infectious diseases. 2000, Vol 30, Num 1, pp 231-233, issn 1058-4838Article

Nonpeptide oxytocin antagonists : Analogs of L-371,257 with improved potencyWILLIAMS, P. D; BOCK, M. G; MICHELSON, S. R et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 9, pp 1311-1316, issn 0960-894XArticle

Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapyABERG, J. A; YAJKO, D. M; JACOBSON, M. A et al.The Journal of infectious diseases. 1998, Vol 178, Num 5, pp 1446-1449, issn 0022-1899Article

Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infectionJACOBSON, M. A; LIU, R. C.-C; DAVIES, D et al.Archives of internal medicine (1960). 1997, Vol 157, Num 16, pp 1825-1831, issn 0003-9926Article

Cloning and chromosomal localization of the human A_2b adenosine receptor gene (ADORA2B) and its pseudogeneJACOBSON, M. A; JOHNSON, R. G; LUNEAU, C. J et al.Genomics (San Diego, Calif.). 1995, Vol 27, Num 2, pp 374-376, issn 0888-7543Article